0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover219.46%IV57.81%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.0366Delta0.0293Gamma94.80Leverage Ratio-0.0043Theta-0.0001Rho-3.47Eff Leverage0.0010Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet